Pharma Journalist 9038 posts 0 comments

Bristol Myers Squibb announced positive results from POETYK PSO-1, the first pivotal Phase 3 trial evaluating deucravacitinib (BMS-986165), a novel, oral, selective tyrosine kinase 2…
Read More...

Ionis Pharmaceuticals, Inc. and its wholly owned subsidiary Akcea Therapeutics, Inc., announced that Pfizer Inc. has initiated a Phase 2b study of vupanorsen (AKCEA-ANGPTL3-LRx) in…
Read More...

GW Pharmaceuticals plc announced that the Company has initiated the first U.S. Phase 3 clinical trial studying nabiximols for multiple sclerosis (MS)-associated spasticity. Nabiximols,…
Read More...

ACG, a leading supplier of integrated pharmaceutical manufacturing solutions announced acquisition of a significant stake in Mumbai-based start-up IQGEN-X. IQGEN-X is a Contract…
Read More...

PerkinElmer, Inc. and Horizon Discovery Group plc are pleased to announce that they have reached an agreement on the terms of a recommended all cash offer whereby PerkinElmer will…
Read More...

Roche announced that the European Commission has approved Tecentriq (atezolizumab) in combination with Avastin (bevacizumab) for the treatment of adult patients with advanced or…
Read More...

SMi Reports: Bachem Group to host an online webinar taking place on Thursday 26th November 2020 on Cost-efficient and Green Manufacturing of Peptides thanks to Molecular Hiving™…
Read More...

Following on from last year’s successful meeting, the 3rd RNA- Targeted Drug Discovery returns this December to unite 100+ key opinion leaders with expert insights for a unique,…
Read More...

Zucara Therapeutics Inc. a diabetes life sciences company developing the first once-daily therapeutic to prevent insulin-induced hypoglycemia (low blood glucose levels), announced that…
Read More...

TFF Pharmaceuticals, Inc. a clinical-stage biopharmaceutical company, and Augmenta Bioworks, Inc., a biotechnology company enabling breakthroughs in medicine through immune profiling,…
Read More...